Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
The field of cancer therapy has seen significant advancements in recent years, with targeted drug delivery systems emerging as a promising approach for improving treatment outcomes. This thesis focuses on the development of novel drug delivery systems specifically designed for targeted cancer therapy. The aim of this research is to address the limitations of traditional chemotherapy by enhancing drug delivery efficiency, reducing side effects, and improving therapeutic efficacy through targeted delivery to cancer cells. Chapter 1 provides an introduction to the research topic, highlighting the background of the study, the problem statement, research objectives, limitations, scope, significance of the study, and the structure of the thesis. The chapter also includes definitions of key terms to provide a clear understanding of the concepts discussed throughout the thesis. Chapter 2 presents a comprehensive literature review that explores existing drug delivery systems for cancer therapy. The review covers various approaches, including nanoparticles, liposomes, micelles, and antibody-drug conjugates, highlighting their advantages and limitations in targeted cancer therapy. Chapter 3 outlines the research methodology employed in this study, including the design and synthesis of novel drug delivery systems, in vitro and in vivo evaluation methods, and data analysis techniques. The chapter also discusses the ethical considerations and regulatory aspects involved in conducting research on drug delivery systems for cancer therapy. Chapter 4 presents the findings of the study, including the characterization of the developed drug delivery systems, in vitro and in vivo evaluation results, and comparison with existing approaches. The chapter includes a detailed discussion of the findings, highlighting the potential of the novel systems for targeted cancer therapy and addressing any challenges encountered during the research. Chapter 5 serves as the conclusion and summary of the thesis, providing a comprehensive overview of the research outcomes, implications for future research, and potential applications of the developed drug delivery systems in clinical settings. The chapter also discusses the significance of the findings in advancing the field of targeted cancer therapy and the potential impact on improving patient outcomes. In conclusion, this thesis contributes to the development of novel drug delivery systems for targeted cancer therapy, offering a promising approach to enhancing the efficacy and safety of cancer treatment. The research findings provide valuable insights into the design and evaluation of targeted drug delivery systems, with implications for future research and clinical applications in oncology.